Quality Investor

Xenia Hotels & Resorts, Inc.

Rank #407Capital ReturnWatchlistCompare with other stocks

XHR · NYSE · Real Estate

Xenia Hotels & Resorts, Inc. (XHR) — Rank #407 by gross profitability (GP/assets 0.12) · ROE 5.7% · Piotroski F-Score N/A.

As-of 2026-10-30 · CIK 0001616000 · all metrics point-in-time as of the filing date.

About

Xenia Hotels & Resorts, Inc. is a self-advised and self-administered REIT that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 lodging markets as well as key leisure destinations in the United States.

Show more

The Company owns 29 hotels and resorts comprising 8,783 rooms across 14 states. Xenia's hotels are in luxury and upper-scale segments and are operated and/or licensed by industry leaders including Marriott, Hyatt, Kimpton, Fairmont, Loews, Hilton, and Davidson. Xenia Hotels & Resorts, Inc.

was incorporated in 2007 and is based in Orlando, United States.

Industry
REIT - Hotel & Motel
Sector
Real Estate
State
FL
Filer Category
Large accelerated filer
Fiscal Year End
December 31

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

42

Industry

REIT - Hotel & Motel

Exchange

NYSE

9/9

Flags passed

XHR passes 9/9 quality flags

  • PASS
    Gross margin holding
  • PASS
    Dilution within 2%
  • PASS
    Disclosure consistent
  • PASS
    Revenue not declining
  • PASS
    Operating margin holding
  • PASS
    Passes safety gate
  • PASS
    Balance sheet stable
  • PASS
    SBC not compressing margin
  • PASS
    No valuation convergence

Strengths Revenue growth accelerating · Operating leverage expanding

No data FCF vs investment · Free cash flow · Competitive position — not counted as a pass.

A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.

Quality Profile

Profitability

1/1 pass
GP / assets
0.12
Return on equity
5.7%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
1.33
Current ratio
—
Net cash
-$1.25B

Cash Flow

1/1 pass
Positive FCF
N/A
Cash-backed earnings
N/A
Accruals healthy
PASS
SBC / revenue
1.2%

Growth

2/2 pass
Revenue growth
3.8%
Piotroski F-Score
N/A
Share dilution
-5.0%

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Does it make money well?

No warning flags · GP/assets 0.12

Gross profitability (GP / assets)

0.12

Primary signal (Novy-Marx).

Return on equity

5.7%

Gross margin

30.6%

Revenue growth (YoY)

3.8%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

2.6%

Revenue CAGR (5Y)

23.9%

Earnings CAGR (3Y)

4.1%

FCF CAGR (3Y)

—

Cash Flow Health

Is the cash real?

No data

Free cash flow

—

Operating cash flow minus capex.

Positive free cash flow

N/A

FCF vs net income

—

(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.

FCF not below net income

Fails when free cash flow is below net income (yellow flag).

N/A

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.2%

Stock-based comp intensity.

Balance Sheet Strength

Can it survive a storm?

No warning flags · net debt $1.25B

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

1.33

Current ratio

—

Quick ratio

—

Net cash

-$1.25B

Cash & equivalents minus total debt.

Piotroski F-Score

N/A

Only 8/9 components determinable.

Valuation

Is the price reasonable?

No warning flags

Dividend safety

Composite score

1.8 / 5

Weak
Payout ratio
0.9%5/5 Strong
FCF coverage
N/A0/5 Weak
Dividend growth streak
1 yr1/5 Weak
Balance-sheet health
D/E 1.33 · IC N/A1/5 Weak

Capital allocation quality

Composite score

2.7 / 5

Fair
Share count trend(net buybacks)
-5.0%4/5 Strong
Buyback timing
N/AN/A
Dividend growth consistency
1 yr1/5 Weak
Net debt trajectory
-0.9%3/5 Good

Lifecycle Phase History

20202025
Decline
Hypergrowth
Value
Capital Return

Price History

XHR+17.1% · +3.2% CAGRSPY+82.9% · +12.8% CAGR